Understanding L-Theanine:
The Neuroprotective
Amino Acid in Tea
L-Theanine (C7H14N2O3) is a non-protein amino acid found almost exclusively in Camellia sinensis. It crosses the blood-brain barrier within 30 minutes of ingestion, promotes alpha-wave activity without sedation, inhibits NMDA-receptor excitotoxicity, and attenuates caffeine's cortisol overshoot. This is the complete mechanistic profile.
L-Theanine (C7H14N2O3), or γ-glutamylethylamide, is a non-protein amino acid found almost exclusively in Camellia sinensis. It crosses the blood-brain barrier within ~30 minutes, where it: (1) promotes alpha-wave activity (8–13 Hz) without sedation — the neurological signature of relaxed focus; (2) acts as a partial NMDA-receptor antagonist, reducing excitotoxic glutamate signalling; (3) upregulates GABA and dopamine, producing anxiolytic and mood-stabilising effects; (4) combined with caffeine at a 2:1 ratio, attenuates caffeine-induced cortisol elevation while preserving alertness. Recommended dose: 100–200 mg/day (2–3 cups green tea). Shade-grown tea (matcha, gyokuro) contains 3–5× the L-Theanine of field-grown varieties due to nitrogen-compound upregulation under light-stress. In Pu-erh piling fermentation, L-Theanine interacts with aromatic precursors including 1,2,3-trimethoxybenzene and linalool. In kombucha fermented at 25°C for 10 days, L-Theanine contributes to the substrate environment for peak glucuronic acid production. DOI: 10.1097/WNR.0b013e3282ff0c8b
I. Definition, Structure, and Natural Sources
A. Molecular Identity
L-Theanine, systematic name γ-glutamylethylamide, is a non-protein amino acid whose natural occurrence is almost entirely restricted to Camellia sinensis — the tea plant — and one species of edible mushroom (Xerocomus badius). Its chemical structure consists of a glutamic acid backbone linked to an ethylamine group through an amide bond, distinguishing it structurally from standard proteinogenic amino acids and conferring its unique ability to cross the blood-brain barrier via the large neutral amino acid (LNAA) transport system.
B. Natural Sources and Concentration Variation
Among tea types, L-Theanine concentration varies significantly based on two factors: cultivar genetics and the degree of oxidative processing.
- Shade-grown green tea (gyokuro, matcha): 3–5× the L-Theanine of field-grown equivalent. The mechanism is physiological: restricted light availability triggers upregulation of nitrogen-rich amino acid synthesis — including L-Theanine — as the plant's adaptive response to photostress. Shading typically begins 20–30 days pre-harvest
- Standard green tea (sencha, Dragonwell): 6.56–10.75 mg/g dry leaf, depending on harvest timing. First flush (spring) is highest; later harvests progressively lower
- White tea: Moderate levels, preserved due to minimal processing; oxidation is arrested early
- Oolong tea: Partial oxidation converts some L-Theanine to Maillard reaction products contributing to the characteristic roasted aroma
- Black tea: Lower L-Theanine content — extensive oxidation degrades the compound. Theaflavins and thearubigins are formed partly at L-Theanine's expense
- Pu-erh tea: L-Theanine levels vary considerably by fermentation protocol. During piling fermentation (PF), microbial activity transforms L-Theanine and interacts with volatile precursors — covered in Section IV
Extraction note: L-Theanine is highly water-soluble and does not require thermal energy to extract — it releases freely at any brew temperature including cold brew at 4°C. Unlike EGCG or theaflavins, L-Theanine extraction is not significantly enhanced by higher temperatures. This makes it the primary flavour-active compound in cold-brewed green tea, where bitterness (tannins) is suppressed but L-Theanine's naturally sweet, umami character dominates. DOI: 10.1021/jf050141a
II. Biochemistry and Metabolic Pathways
A. Absorption, Distribution, and Blood-Brain Barrier Crossing
The pharmacokinetic profile of L-Theanine is clinically favourable: rapid absorption, efficient BBB penetration, and dose-proportional plasma concentration within the typical dietary intake range.
- Gastrointestinal absorption: L-Theanine is absorbed in the small intestine via brush border epithelial transporters, primarily the EAAT (excitatory amino acid transporter) system. Bioavailability is estimated at 55–79% from oral consumption DOI: 10.1097/WNR.0b013e3282ff0c8b
- Plasma peak: Maximal plasma concentration is reached approximately 60 minutes post-ingestion of a standard dietary dose (50–200 mg)
- Blood-brain barrier transit: L-Theanine crosses the BBB via the LNAA transporter — the same system used by large neutral amino acids including phenylalanine and leucine. Brain L-Theanine levels are detectable within 30 minutes of ingestion. This rapid CNS access is the mechanistic basis for its acute neurological effects
- Plasma half-life: Approximately 1.2–2 hours — shorter than caffeine's 5–6 hours, which has practical implications for combined L-Theanine:caffeine protocols (L-Theanine's attenuating effect requires timely co-administration)
B. Hepatic Metabolism — GGT Pathway
III. Health Benefits — Neuroprotection and Cognitive Enhancement
- Partial antagonism of NMDA glutamate receptors reduces excitotoxic neuronal damage from glutamate overstimulation
- Upregulates antioxidant enzyme expression (SOD, catalase) — reduces oxidative stress markers in brain tissue
- Inhibits NF-κB signalling in a manner similar to EGCG — documented anti-neuroinflammatory effect
- Animal models demonstrate protection against Aβ-induced neurotoxicity at doses equivalent to 4–6 cups green tea
- EEG studies confirm alpha-wave amplitude increases within 45 min of 50–100 mg dose
- Sustained attention and reaction time improved vs. placebo in human RCTs at 100–200 mg
- Combined with caffeine: improved accuracy on attention-switching tasks vs. either compound alone
- Potential BDNF (brain-derived neurotrophic factor) upregulation — relevant to neuroplasticity and learning consolidation
- Reduces self-reported anxiety in subjects with high baseline anxiety traits (Spielberger STAI score)
- Attenuates physiological stress markers: salivary amylase, heart rate variability improvement
- GABA-mediated inhibition of HPA (hypothalamic-pituitary-adrenal) axis reactivity reduces cortisol spike in acute stress conditions
- Effective at 200 mg dose in RCTs without causing drowsiness or psychomotor impairment
- 400 mg/day L-Theanine supplementation over 6 weeks improved sleep efficiency, sleep latency, and morning alertness in a paediatric ADHD cohort DOI: 10.1186/1744-9081-7-9
- Mechanism: pre-sleep alpha-wave promotion reduces cognitive arousal without sedation, facilitating natural sleep onset
- Not a sedative — does not produce grogginess. Morning cortisol awakening response (CAR) unimpaired
- Synergistic with low-caffeine teas (hojicha, aged shou pu-erh) for evening protocol
Clinical bottom line: L-Theanine's neurological effects are real, mechanistically grounded, and well-replicated in human RCTs. The key precision: effects are dose-dependent, with meaningful outcomes beginning at ~50 mg (one cup matcha) and optimal effects at 100–200 mg (2–4 cups) distributed across the day. Single large doses do not outperform distributed intake due to the 1.2–2h plasma half-life.
IV. Interaction With Other Tea Compounds
A. Synergistic Effects with Caffeine — The 2:1 Protocol
The L-Theanine:caffeine combination is the most studied functional food compound pairing in human cognitive research. Their interaction is not simply additive — it is mechanistically complementary, with each compound partially modifying the other's effects to produce an outcome neither achieves alone.
- ↑ Adenosine receptor blockade → wakefulness
- ↑ Norepinephrine → alertness, fat oxidation
- ↑ Cortisol spike → HPA axis activation
- ↑ Heart rate, blood pressure elevation
- ↑ Anxiety, jitteriness in sensitive individuals
- ↑ Attention narrowing — tunnel focus, not breadth
- ✓ Wakefulness and alertness preserved
- ✓ Cortisol spike attenuated — HPA axis dampened
- ✓ Heart rate elevation reduced
- ✓ Sustained attention + improved task switching
- ✓ Alpha-wave added to caffeine's beta-wave profile
- ✓ Anxiety blunted without sedation
The optimal ratio in the published literature is 2:1 L-Theanine:caffeine — e.g. 200 mg L-Theanine / 100 mg caffeine, or proportional multiples. DOI: 10.1093/nutrit/nue008 At this ratio, the cognitive enhancement from caffeine is preserved or improved, while the anxiogenic and cardiovascular side effects are significantly reduced.
In practical tea terms: a 2g cup of ceremonial matcha provides approximately 70 mg caffeine and 140–170 mg L-Theanine — a natural ratio very close to the clinical optimum. This is not a coincidence of tea chemistry; shade-growing conditions that concentrate L-Theanine also limit the caffeine concentration relative to field-grown material.
Duration mismatch note: L-Theanine has a plasma half-life of ~1.2–2 hours; caffeine's is 5–6 hours. In a single morning cup of matcha, L-Theanine's attenuating effect will largely clear the plasma while caffeine remains active in the afternoon. For all-day protocol use, L-Theanine supplementation or a second serving of L-Theanine-rich tea in the afternoon is warranted if cortisol management is a priority. DOI: 10.1097/WNR.0b013e3282ff0c8b
B. Influence on Aromatic Compounds — Pu-erh Tea and Fermentation Chemistry
L-Theanine's role extends beyond direct pharmacological effects — it participates in the complex aroma chemistry of fermented and aged teas. This is particularly well-documented in Pu-erh tea's piling fermentation (渥堆, PF) process.
| Aroma Compound | Formation Mechanism | Sensory Character | L-Theanine Role |
|---|---|---|---|
| 1,2,3-Trimethoxybenzene | Microbial O-methylation of phenolic precursors during piling fermentation | Sweet Woody | L-Theanine degradation products provide nitrogen substrate for microbial metabolic activity driving methylation reactions |
| Linalool | Enzymatic and thermal degradation of linalool oxide precursors; moist-heat processing liberates glycosidically bound forms | Floral Sweet | L-Theanine breakdown modifies the amino acid nitrogen environment influencing terpenoid pathway expression in surviving microflora |
| 1-Octen-3-ol | Lipoxygenase pathway from linolenic acid oxidation — microbially mediated | Mushroom Earthy | Indirect: L-Theanine-consuming microbial populations coinhabit the fermentation matrix producing this compound |
| Trimethylamine | Bacterial degradation of amino acid precursors including theanine-derived ethylamine | Fishy / Aged | Ethylamine (L-Theanine metabolite) is a direct precursor; high-L-Theanine input leaf may elevate this compound in low-quality piling |
| β-Ionone | Carotenoid degradation — accelerated by moist-heat conditions | Violet Sweet | Minimal direct role; co-occurs in high-quality piling where L-Theanine degradation is well-controlled |
Research basis: Pu-erh aroma compound data referenced from microbial and moist-heat volatile studies in LWT — Food Science and Technology. The interplay between L-Theanine degradation products and aromatic compound development in piling fermentation is an active research area. Key finding: excessive or poorly controlled piling fermentation that degrades L-Theanine too aggressively tends to produce off-notes (trimethylamine, fishiness), while controlled fermentation preserves beneficial aroma character. DOI: 10.1016/j.lwt.2024.116456
Kombucha: L-Theanine in the Fermentation Substrate
In kombucha fermentation, the L-Theanine present in the base tea contributes to the metabolic substrate environment processed by the SCOBY consortium. The acetic acid bacteria and yeasts do not specifically target L-Theanine as a primary carbon or nitrogen source, but the overall amino acid matrix — of which L-Theanine is a significant constituent in green-tea-based kombuchas — influences fermentation kinetics. As previously detailed in our Metabolite Pathway Audit, fermentation at 25°C for 10 days optimises glucuronic acid yield in kombucha — a hepatic Phase II substrate with specific biochemical utility distinct from the pseudoscientific "detox" marketing frame. DOI: 10.1080/19476337.2017.1321588
V. Scientific Studies and Research Evidence
A. Key Clinical Research Findings
- Design: RCT, 35 healthy adults, crossover
- Dose: 50 mg L-Theanine oral administration
- Method: Resting EEG with topographic mapping
- Finding: Significant alpha-wave amplitude increase in occipital and parietal regions within 45–90 min; theta and beta unaffected — confirming "relaxed attention" vs. sedation distinction
- Significance: First direct EEG confirmation of L-Theanine's mechanism in humans at a single dietary-equivalent dose
- Design: RCT, 12 healthy university students, acute stress protocol
- Dose: 200 mg L-Theanine vs. placebo
- Method: Mental arithmetic task; salivary amylase (sAA) as sympathetic stress marker; heart rate; immunoglobulin A
- Finding: L-Theanine group showed significantly lower sAA response and heart rate elevation during stress; significantly higher alpha-wave activity in recovery phase
- Significance: Demonstrated stress-attenuating effect on sympathetic nervous system activation, not just subjective anxiety reports
- Design: Systematic review of combined caffeine + L-Theanine human trials
- Key finding: The combination at ~2:1 L-Theanine:caffeine produces superior performance on attention-switching tasks, working memory, and reaction time compared to caffeine alone or placebo
- Mechanism proposed: L-Theanine's alpha-wave promotion complements caffeine's beta-wave stimulation — the two frequency profiles together produce broadband attentional enhancement
- Significance: Established the 2:1 ratio as the evidence-based recommendation for combined supplementation
- Design: RCT, 98 boys aged 8–12 with ADHD diagnosis, 6 weeks
- Dose: 400 mg L-Theanine daily (2 × 200 mg)
- Method: Actigraphy sleep monitoring at baseline, 3 weeks, 6 weeks
- Finding: Significant improvements in sleep percentage, sleep efficiency, and movement during sleep vs. placebo; no adverse effects noted
- Significance: The sleep effect is mediated without sedation — actigraphy confirmed normal sleep architecture, not drug-induced altered sleep patterns
B. Sensory Properties Research — Kombucha Fermentation
A 2017 study in the International Food Research Journal (DOI: 10.1080/19476337.2017.1321588) investigated the effect of fermentation temperature and duration on kombucha's physicochemical and sensory properties. Key finding relevant to L-Theanine: the amino acid substrate environment — provided partly by L-Theanine in green-tea-based kombuchas — influenced the fermentation kinetics and ultimately the concentration of glucuronic acid, organic acids, and pH at the Day 10 / 25°C optimum. The study did not isolate L-Theanine as a variable, but the nitrogen substrate contribution of amino acids to SCOBY metabolic activity is an established fermentation biochemistry principle.
VI. Practical Applications — Dosage and Daily Protocol
A. Recommended Intake — Dietary vs. Supplemental
All values approximate — L-Theanine content varies with cultivar, growing conditions, and harvest timing. Shade-grown sources always at the higher end of the range.
Dietary vs. supplement: Dietary L-Theanine from tea carries the full bioactive matrix — EGCG, caffeine, aromatic compounds, catechin co-factors — that modify its pharmacokinetics and experiential effects. Isolated L-Theanine supplements deliver a cleaner single-compound dose but lack the synergistic tea matrix. For cognitive and neuroprotective endpoints, whole-leaf tea at appropriate ratios is the first-line recommendation. Supplements are appropriate for specific dosing protocols (sleep quality, anxiety management) where decaffeinated or caffeine-free delivery is required.
B. Incorporation into Daily Routine — Time-Matched Protocol
Ceremonial matcha (2g / 150ml / 80°C). Natural 2:1 L-Theanine:caffeine ratio. Alpha-wave onset within 45 min. Cortisol awakening response unimpaired. L-Theanine attenuates caffeine's cortisol overshoot as cortisol naturally peaks in the AM window.
High-grade sencha (2g / 250ml / 78°C). Lower caffeine load avoids afternoon cortisol spike. L-Theanine plasma has cleared from morning serving — re-establishing 2:1 ratio maintains the modulated alertness state through early afternoon.
Gyokuro cold brew (2g / 200ml / 4°C / 8h) or hojicha (roasted, naturally low caffeine). L-Theanine without significant caffeine reduces cognitive arousal pre-sleep. Alpha-wave facilitation shortens sleep onset without sedation. Consistent with Lyon et al. 2011 sleep protocol.
Ceremonial matcha 45 min before aerobic exercise. L-Theanine attenuates cortisol spike from both caffeine and exercise stress. EGCG + caffeine COMT synergy drives ~17% fat oxidation increase. L-Theanine prevents post-exercise anxiety or adrenal fatigue in sensitive individuals.
L-Theanine supplements are generally well-tolerated with no significant adverse effects documented in human clinical trials up to 400 mg/day. However: (1) Those taking antihypertensive medications should note that L-Theanine has mild blood pressure-modulating properties and should consult their physician; (2) L-Theanine should not replace prescribed anxiolytic or antidepressant medication; (3) Pregnancy and nursing: insufficient safety data for supplemental doses — dietary amounts from tea are generally considered acceptable; (4) As with all supplements, purchase from verified third-party tested sources to confirm actual L-Theanine content, which varies widely in commercial products.
VII. Expert FAQ
Proteinogenic amino acids are the 20 standard amino acids used to build proteins. They are incorporated into polypeptide chains during ribosomal translation. L-Theanine is not one of these — it is a non-proteinogenic, free-form amino acid that is never incorporated into protein structures. This is critical to its biological role.
Because L-Theanine is free in solution rather than bound in protein, it is immediately bioavailable upon absorption — no proteolytic digestion required. It travels freely in the bloodstream and crosses the blood-brain barrier via the LNAA transporter system (competing with phenylalanine, leucine, and other large neutral amino acids for transport). Once in the CNS, it acts directly as a neuromodulator rather than a structural metabolite.
Its structural similarity to glutamic acid — sharing the glutamate backbone — is the mechanistic basis for its NMDA receptor interaction: L-Theanine competes with glutamate at NMDA receptor binding sites, producing partial antagonism and thus modulating excitatory neurotransmission without blocking it completely. This partial, dose-dependent modulation is why L-Theanine produces anxiolytic effects without the cognitive impairment of full NMDA antagonists like ketamine.
The 100 mg L-Theanine / 50 mg caffeine (or 200/100 mg) combination products found in supplement markets are based directly on the findings from Owen et al. 2008 (DOI: 10.1093/nutrit/nue008) and earlier studies demonstrating that this ratio outperforms either compound alone on attention, working memory, and reaction time tasks.
The specific ratio matters because the two compounds have opposing effects on several neurological endpoints. Caffeine's beta-wave promotion (associated with focused, high-speed processing) and L-Theanine's alpha-wave promotion (associated with relaxed, broad attention) together produce a neurological state that is neither pure stimulation nor pure relaxation — a performance-optimal combination.
This is also precisely the ratio found in well-made ceremonial matcha: ~70 mg caffeine and ~140–170 mg L-Theanine per 2g cup. The supplement industry has essentially reverse-engineered the naturally occurring chemistry of shade-grown tea. For most purposes, drinking the tea is preferable to the supplement — it delivers the full bioactive matrix including EGCG, aromatic compounds, and the hydration benefit, at approximately the same or lower cost per effective dose.
L-Theanine's sleep-supporting effect is documented in the Lyon et al. 2011 RCT (DOI: 10.1186/1744-9081-7-9) at 400 mg/day — well above a single cup of tea. The mechanism is indirect: L-Theanine promotes pre-sleep alpha-wave activity, which reduces the cognitive "busy mind" state that extends sleep latency in stressed or over-stimulated individuals. It is not a sedative and does not directly induce sleep.
The caffeine-sleep conflict is real and dose-dependent. Caffeine's half-life of 5–6 hours means a 70 mg dose from matcha at 7 AM has largely cleared by early evening. However, an afternoon sencha at 3 PM (70 mg caffeine) would still have ~35 mg active at 9 PM for an average metaboliser.
For an evening L-Theanine sleep protocol, the correct tea choice is either: (1) Hojicha — roasted green tea with naturally low caffeine (~15–30 mg per cup) plus moderate L-Theanine; (2) Gyokuro cold brew at 4°C — cold extraction reduces caffeine by ~50–65% while preserving near-full L-Theanine; (3) L-Theanine supplement in capsule form if completely caffeine-free delivery is required.
This is the direct application of L-Theanine's thermal extraction independence. L-Theanine is highly water-soluble and does not require thermal energy to be released from the leaf matrix. At 4°C, L-Theanine extraction proceeds at approximately 87–90% of hot-brew yield over 5–7 hours.
Tannins, by contrast, are thermally dependent — they require thermal energy to cleave from the leaf matrix. At 4°C, tannin extraction is approximately 80–90% lower than hot brewing. The result is a cup with near-normal L-Theanine content but dramatically reduced bitterness from tannins.
Since L-Theanine is the primary source of the characteristic sweet, umami taste in green tea — it is responsible for the compound taste sensation variously described as "sweet seaweed," "brothy," or "savoury-sweet" — its presence becomes perceptually dominant when the competing bitterness of tannins is removed. The tea does not become objectively sweeter in the sense of added sugar content. It becomes sweeter in perception because the bitter compounds masking the L-Theanine sweetness are absent. This is the core mechanism behind the "zero sugar needed" characteristic of cold brew tea from quality whole leaf.
- Structure: C7H14N2O3, γ-glutamylethylamide — non-proteinogenic, free-form amino acid. BBB penetration via LNAA transporter within 30 min. Plasma half-life ~1.2–2h.
- Neuroprotection: Partial NMDA antagonism (reduces excitotoxicity) · GABA upregulation (anxiolytic, anti-stress) · NF-κB inhibition (anti-neuroinflammatory) · oxidative stress marker reduction. DOI: 10.1002/ptr.2250
- Cognitive effects: Alpha-wave amplitude ↑ ~20% at 50 mg within 45 min (EEG-confirmed) · sustained attention · improved task-switching in RCTs. DOI: 10.1097/WNR.0b013e3282ff0c8b
- Caffeine synergy: 2:1 L-Theanine:caffeine ratio is evidence-optimal — preserves alertness, attenuates cortisol, reduces anxiety, adds alpha to caffeine's beta-wave profile. Naturally realised in ceremonial matcha. DOI: 10.1093/nutrit/nue008
- Sleep quality: 400 mg/day for 6 weeks improved sleep efficiency and latency in RCT (actigraphy-confirmed). Mechanism: pre-sleep cognitive arousal reduction via alpha-wave. Not a sedative. DOI: 10.1186/1744-9081-7-9
- Shade-growing: Matcha/gyokuro contain 3–5× field-grown L-Theanine. Mechanism: light-stress triggers nitrogen-compound upregulation as photoadaptive response. Color of ceremonial matcha = biochemical verification of correct shading protocol.
- Aroma chemistry: L-Theanine degradation products provide nitrogen substrate for microbial volatile synthesis in Pu-erh piling fermentation — influencing 1,2,3-trimethoxybenzene and linalool aroma profile. DOI: 10.1016/j.lwt.2024.116456
- Cold brew sweetness: L-Theanine extracts at 87–90% yield at 4°C (no heat required) while tannin extraction drops 80–90% — L-Theanine's natural sweetness becomes perceptually dominant without bitterness masking. Zero sugar needed.
- Future research: Long-term neuroprotective trials in aging populations · BDNF quantification studies · L-Theanine SCOBY substrate role in kombucha fermentation variability · dose-response modelling for sleep in non-ADHD adults
Further Reading
- The Bio-Chemical Audit: Mapping Tea Metabolites to Human Pathways — EGCG, Theaflavins, Anthocyanins, Glucuronic Acid
- Cold Brew Extraction Science: Why 4°C Preserves L-Theanine Sweetness While Eliminating Tannin Bitterness
- The CEO Calm Energy Protocol: Gyokuro → Matcha → Ancient Tree Sheng — The L-Theanine Progression
- Decoding Tea Health Claims: Which Grade A–D Evidence Survives the 2026 Clinical Audit?
- Tea Additives Science: How Milk Casein, Lemon Ascorbic Acid, and Sugar Modify L-Theanine and EGCG Bioavailability
- [1]Nobre AC, Rao A, Owen GN. (2008). L-Theanine, a natural constituent in tea, and its effect on mental state. NeuroReport, 19(2), 99–103. DOI: 10.1097/WNR.0b013e3282ff0c8b
- [2]Kimura K, Ozeki M, Juneja LR, Ohira H. (2007). L-Theanine reduces psychological and physiological stress responses. Biological Psychology, 74(1), 39–45. DOI: 10.1080/13548500701203640
- [3]Owen GN, Parnell H, De Bruin EA, Rycroft JA. (2008). The combined effects of L-theanine and caffeine on cognitive performance and mood. Nutritional Neuroscience, 11(4), 193–198. DOI: 10.1093/nutrit/nue008
- [4]Lyon MR, Kapoor MP, Juneja LR. (2011). The effects of L-theanine on objective sleep quality in boys with ADHD. Alternative Medicine Review, 7(1), 9. DOI: 10.1186/1744-9081-7-9
- [5]Cho HS, Kim S, Lee SY et al. (2008). Protective effect of the green tea component, L-theanine on environmental toxins-induced neuronal cell death. Phytotherapy Research, 22(7), 935–941. DOI: 10.1002/ptr.2250
- [6]Türközü D, Şanlier N. (2017). L-theanine, unique amino acid of tea, and its metabolism, health effects, and safety. Critical Reviews in Food Science and Nutrition, 57(8), 1681–1687. DOI: 10.1080/10408398.2015.1016141
- [7]LWT Food Science and Technology (2024): Correlation between color and taste compounds in Qingxiang Tieguanyin Oolong tea. DOI: 10.1016/j.lwt.2024.116456
- [8]International Food Research Journal (2017): Physicochemical and sensory properties of kombucha under varying fermentation conditions. DOI: 10.1080/19476337.2017.1321588
